Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Pennsylvania
- Enrollment
- 4,774
- Locations
- 2
- Primary Endpoint
- Statin Prescribing Rate
Study Overview
Brief Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Detailed Description
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Strong evidence indicates that statin medications can reduce the risk of CVD and for those with CVD statins have been shown to reduce mortality. Despite this evidence, statins are under-prescribed. In this study, the investigators will test the effectiveness of nudges targeted to physicians using active choice and social comparisons feedback to increasing the rate at which statin medications are prescribed to patients eligible based on national practice guidelines.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 40 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patient has a primary care physician at University of Pennsylvania Health System
- •Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record
Exclusion Criteria
- •Patient has an allergy or adverse reaction to statins documented in the electronic health record
- •Patient has glomerular filtration rate less than 30 mL/min
- •Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin
Arms & Interventions
Control
No intervention
Active choice
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.
Intervention: Active choice (Behavioral)
Active choice with social comparison feedback
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers
Intervention: Active choice (Behavioral)
Active choice with social comparison feedback
Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers
Intervention: Social comparison feedback (Behavioral)
Outcomes
Primary Outcomes
Statin Prescribing Rate
Time Frame: Two Months
Percentage of patients eligible for a statin that have been prescribed a statin
Secondary Outcomes
No secondary outcomes reported